Inventor · disambiguated record

Luigi Franchi

Also filed as: FRANCHI LUIGI

15 granted patents·12 pending applications·51 citations·filing 1973–2024

92Inventor score

Technology areasC07D A61K A61P C07K G03C

Files withFIRST WAVE BIO INC11 NOVARTIS AG11 MINNESOTA MINING & MFG2 IFM THERAPEUTICS INC1 INNATE TUMOR IMMUNITY INC1

Top patents by PatentIndex Score

27 records

0197US10744103B2Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2020·Granted Aug 18, 2020·7 cites·29 claims
0296US10772854B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2018·Granted Sep 15, 2020·6 cites·72 claims
0395US10912746B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2020·Granted Feb 9, 2021·3 cites·20 claims
0495US10905666B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2020·Granted Feb 2, 2021·3 cites·26 claims
0595US10849867B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2020·Granted Dec 1, 2020·3 cites·28 claims
0695US10799468B2Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2020·Granted Oct 13, 2020·3 cites·28 claims
0794US10292951B2Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2016·Granted May 21, 2019·9 cites·60 claims
0890US11724992B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2021·Granted Aug 15, 2023·1 cites·20 claims
0987US2024074995A1Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2023·Application pending·0 cites
1084US12084424B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2023·Granted Sep 10, 2024·0 cites·3 claims
1184US11370763B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Jun 28, 2022·1 cites·13 claims
1284US10654816B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS INFLAMMASOME RES INC·Filed 2019·Granted May 19, 2020·3 cites·19 claims
1381US11203579B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Dec 21, 2021·2 cites·19 claims
1478US11793777B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2021·Granted Oct 24, 2023·0 cites·18 claims
1577US2024391884A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2024·Application pending·0 cites
1677US2022000812A1Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2021·Application pending·0 cites
1775US2020276140A1Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2020·Application pending·0 cites
1863US2019064146A1Immune cells having increased immunity or resistance to an immunosuppressive cytokine and use of the sameINNATE TUMOR IMMUNITY INC·Filed 2018·Application pending·0 cites
1960US2023079631A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2022·Application pending·0 cites
2053US2021395241A1Nlrp modulatorsNOVARTIS AG·Filed 2019·Application pending·0 cites
2150US2017056448A1Immune cells having increased immunity or resistance to an immunosuppressive cytokine and use of the sameIFM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
2249US2022339169A1Methods of treating or selecting a treatment for a subject resistant to tnf inhibitor using a nlrp3 antagonistNOVARTIS AG·Filed 2019·Application pending·0 cites
2348US2023059136A1The compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2019·Application pending·0 cites
2448US2023051589A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2019·Application pending·0 cites
2546US3933494AMethod for obtaining a color contrast photographic image by color development and silver salt diffusion transfer processing of one photographic elementMINNESOTA MINING & MFG·Filed 1973·Granted Jan 20, 1976·7 cites·13 claims
2646US2022267276A1Nlrp modulatorsNOVARTIS AG·Filed 2019·Application pending·0 cites
2743US3941599AMethod for obtaining a color contrast photographic image, photographic element and development composition suitable for the realization of said methodMINNESOTA MINING & MFG·Filed 1975·Granted Mar 2, 1976·3 cites·7 claims

Join the waitlist — get patent alerts

Get an alert when Luigi Franchi files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →